Israel approves coronavirus vaccines for younger children
Israel on Sunday approved giving the COVID-19 vaccine to children between the ages of 5 and 11. The Health Ministry […]
Israel on Sunday approved giving the COVID-19 vaccine to children between the ages of 5 and 11. The Health Ministry […] June 21, 2021 — Today, the U.S. Food and Drug Administration approved Pradaxa (dabigatran etexilate) oral pellets to treat children […] Fox News Flash top headlines for June 7 Fox News Flash top headlines are here. Check out what’s clicking on […] Nurtec ODT 75 mg is the first oral CGRP antagonist approved to prevent migraine Nurtec ODT 75 mg is now […] FDA Approves Zegalogue (dasiglucagon) Injection for the Treatment of Severe Hypoglycemia in People with Diabetes Copenhagen, DK and Boston, MA, […] Chile on Wednesday became the latest country to give emergency approval to China’s CoronaVac vaccine as it battles the coronavirus […] FDA Approves Klisyri (tirbanibulin) for the Treatment of Actinic Keratosis on the Face or Scalp BUFFALO, N.Y., Dec. 15, 2020 […] FDA Approves Qdolo (tramadol hydrochloride) Oral Solution for the Management of Severe Pain ATHENS, Ga., Sept. 8, 2020 /PRNewswire/ — […] (HealthDay)—A new drug to treat most cystic fibrosis patients has been approved by the U.S. Food and Drug Administration. Trikafta […] (HealthDay)—Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. […]approves
Israel approves coronavirus vaccines for younger children
FDA Approves Pradaxa (dabigatran) as First Oral Blood Thinning Medication for Children
FDA approves new weight loss drug, first since 2014
FDA Approves Biohaven’s Nurtec ODT (rimegepant) for Preventative Treatment of Migraine
FDA Approves Zegalogue
Chile approves Chinese coronavirus vaccine
FDA Approves Klisyri
FDA Approves Qdolo
FDA approves new drug for most common form of cystic fibrosis
FDA approves venetoclax for chronic, small lymphocytic leukemia
Copyright © 2025